Quote For GlaxoSmithKline PLC GSK.N
sector: Healthcare ·
industry: Pharmaceuticals - Diversified ·
As of
8:16pm GMT
42.40USD
$42.40
8:16pm GMT
-0.02%
$42.41
$42.72
293,200
$42.79
$42.39
$42.98
$27.15
0.41
1,718,010
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Gent, Christopher |
Non-Executive Chairman of the Board |
651,000 |
| Witty, Andrew |
Chief Executive Officer, Executive Director |
1,778,000 |
| Heslop, Julian |
Chief Financial Officer, Executive Director |
926,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$66,420.30 |
| Shares Outstanding (Mil.) |
5,189.08 |
| Float (Mil.) |
5,172.70 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend ($ USD) |
0.57 |
| Payout Ratio(TTM) % |
62.13 |
| |
| Financial Strength |
| Quick Ratio |
1.32 |
| Current Ratio |
1.56 |
| LT Debt/Equity |
162.02 |
| Total Debt/Equity |
184.94 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
13.38 |
| Price/Sales(TTM) |
2.44 |
| Price/Book(TTM) |
7.16 |
| Price/Cash Flow(TTM) |
9.74 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$0.96 |
| Sales(TTM) |
$5.33 |
| Book Value(MRQ) |
$1.79 |
| Cash Flow(TTM) |
$1.34 |
| Cash(MRQ) |
$1.35 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
58.25 |
| Return on Assets(TTM) |
13.33 |
| Return on Investment(TTM) |
18.34 |
| |
|
| Margins |
| Gross Margin(TTM) % |
75.39 |
| Operating Margin(TTM) % |
27.79 |
| Profit Margin(TTM) % |
18.46 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives